Literature DB >> 18214750

Preparation, physical properties, and stability of gambogic acid-loaded micelles based on chitosan derivatives.

Xian Zhu1, Can Zhang, Xiaoli Wu, Xiaoyan Tang, Qineng Ping.   

Abstract

The objective of this study is to find out an optimized formulation of water insoluble anticancer drug gambogic acid (GA)-loaded chitosan derivatives micelles. After preliminary test, four factors (the amount of N-octyl-O-sulfate chitosan (AOSC), the amount of GA, volume of ethanol, and dialysis temperature) and three levels for each factor that might affect the formation of micelles were selected and arranged in L9 (3(4)) orthogonal experimental design to optimize the formulation of GA-loaded micelles. To compare each of the micellar formulations quantitatively, an overall desirability function was defined and calculated based on three assessment indices (drug content, loading efficiency, and entrapping efficiency of micelles). The optimized formulation was 8 mg of GA dissolved in 0.3 mL of ethanol, 12 mg of AOSC dissolved in 2 mL of H2O, respectively. The drug solution and blank micellar solution were mixed, followed by dialysis against water at 25 degrees C. The mean size of micelle was 100 nm approximately. Lyophilized samples could keep stable for at least 2 months when it was stored at 4 degrees C. These data suggest that the amphiphilic chitosan derivative may improve the water solubility of GA and thus be used as its nano-carrier.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18214750     DOI: 10.1080/03639040701378001

Source DB:  PubMed          Journal:  Drug Dev Ind Pharm        ISSN: 0363-9045            Impact factor:   3.225


  8 in total

Review 1.  Chemistry and biology of the caged Garcinia xanthones.

Authors:  Oraphin Chantarasriwong; Ayse Batova; Warinthorn Chavasiri; Emmanuel A Theodorakis
Journal:  Chemistry       Date:  2010-09-03       Impact factor: 5.236

Review 2.  Recent research on bioactive xanthones from natural medicine: Garcinia hanburyi.

Authors:  Buyun Jia; Shanshan Li; Xuerui Hu; Guangyu Zhu; Weidong Chen
Journal:  AAPS PharmSciTech       Date:  2015-07-08       Impact factor: 3.246

3.  Single-walled carbon nanotube and graphene nanodelivery of gambogic acid increases its cytotoxicity in breast and pancreatic cancer cells.

Authors:  Lamya M Saeed; Meena Mahmood; Sebastian J Pyrek; Tariq Fahmi; Yang Xu; Thikra Mustafa; Zeid A Nima; Stacie M Bratton; Dan Casciano; Enkeleda Dervishi; Anna Radominska-Pandya; Alexandru S Biris
Journal:  J Appl Toxicol       Date:  2014-09-12       Impact factor: 3.446

4.  Study of the enhanced anticancer efficacy of gambogic acid on Capan-1 pancreatic cancer cells when mediated via magnetic Fe3O4 nanoparticles.

Authors:  Cailian Wang; Haijun Zhang; Baoan Chen; Haitao Yin; Wenwen Wang
Journal:  Int J Nanomedicine       Date:  2011-09-09

5.  Gambogic acid-loaded magnetic Fe(3)O(4) nanoparticles inhibit Panc-1 pancreatic cancer cell proliferation and migration by inactivating transcription factor ETS1.

Authors:  Cailian Wang; Haijun Zhang; Yan Chen; Fangfang Shi; Baoan Chen
Journal:  Int J Nanomedicine       Date:  2012-02-14

6.  Cell penetrating peptides functionalized gambogic acid-nanostructured lipid carrier for cancer treatment.

Authors:  Rui Huang; Jiawei Li; Dereje Kebebe; Yumei Wu; Bing Zhang; Zhidong Liu
Journal:  Drug Deliv       Date:  2018-11       Impact factor: 6.419

7.  Aminated β-cyclodextrin-grafted Fe3O4-loaded gambogic acid magnetic nanoparticles: preparation, characterization, and biological evaluation.

Authors:  Wei Fang; Ya Ji Dai; Ting Wang; Hai Tao Gao; Peng Huang; Juan Yu; He Ping Huang; Dian Lei Wang; Wei Lu Zong
Journal:  RSC Adv       Date:  2019-08-29       Impact factor: 4.036

Review 8.  Recent Advances in Nanotechnology with Nano-Phytochemicals: Molecular Mechanisms and Clinical Implications in Cancer Progression.

Authors:  Bonglee Kim; Ji-Eon Park; Eunji Im; Yongmin Cho; Jinjoo Lee; Hyo-Jung Lee; Deok-Yong Sim; Woon-Yi Park; Bum-Sang Shim; Sung-Hoon Kim
Journal:  Int J Mol Sci       Date:  2021-03-30       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.